NCT03029897View on ClinicalTrials.gov

E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

April 24, 2019

Study Completion Date

April 24, 2019

Conditions
Multiple Sclerosis
Interventions
OTHER

My eReport France

"patients are educated to the use of My eReport France application"

Trial Locations (1)

14000

CHU Caen, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT03029897 - E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis | Biotech Hunter | Biotech Hunter